GPP
Great Point Partners’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.65M | Sell |
323,170
-691,197
| -68% | -$7.81M | 2.38% | 16 |
|
|
2025
Q1 | $11.7M | Sell |
1,014,367
-772,636
| -43% | -$8.92M | 6.2% | 2 |
|
|
2024
Q4 | $15.1M | Buy |
1,787,003
+487,500
| +38% | +$4.13M | 7.13% | 3 |
|
|
2024
Q3 | $15M | Sell |
1,299,503
-39,065
| -3% | -$452K | 4.43% | 7 |
|
|
2024
Q2 | $15.8M | Buy |
+1,338,568
| New | +$15.8M | 3.02% | 13 |
|
|
2023
Q2 | – | Sell |
-1,600,545
| Closed | -$12.6M | – | 42 |
|
|
2023
Q1 | $12.6M | Buy |
1,600,545
+544,744
| +52% | +$4.28M | 2.47% | 19 |
|
|
2022
Q4 | $7.14M | Sell |
1,055,801
-495,918
| -32% | -$3.35M | 1.4% | 23 |
|
|
2022
Q3 | $22.5M | Buy |
1,551,719
+21,719
| +1% | +$315K | 5.42% | 7 |
|
|
2022
Q2 | $15.1M | Buy |
1,530,000
+655,803
| +75% | +$6.45M | 3.61% | 10 |
|
|
2022
Q1 | $12.9M | Buy |
874,197
+462,260
| +112% | +$6.81M | 3.11% | 15 |
|
|
2021
Q4 | $5.45M | Buy |
+411,937
| New | +$5.45M | 1.21% | 28 |
|